Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of methotrexate and naproxen represents a potential drug interaction rather than a single formulated product. This combination is commonly encountered in clinical practice, particularly for patients with rheumatoid arthritis who may be prescribed both medications. Methotrexate is an immunosuppressant and antineoplastic agent used to treat various inflammatory conditions and cancers. Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) used for pain relief and reducing inflammation. ## Interaction Significance The interaction between methotrexate and naproxen is considered clinically significant, particularly at higher doses of methotrexate. The primary concerns include: 1. **Increased risk of methotrexate toxicity** due to reduced renal elimination when taken with NSAIDs like naproxen. 2. **Potential for renal toxicity** when these medications are used together. The severity of this interaction appears to be dose-dependent. At low doses of methotrexate (as used in rheumatoid arthritis), the risk may be lower than with high doses (as used in chemotherapy regimens). ## Clinical Management Despite the potential interaction, methotrexate and NSAIDs are commonly prescribed together for patients with rheumatoid arthritis who need both medications. Management approaches include: - Using the combination with caution under specialist supervision (e.g., rheumatologist). - Regular monitoring of laboratory values to detect signs of methotrexate toxicity. - Counseling patients to avoid purchasing over-the-counter NSAIDs without consulting their healthcare provider. - Advising patients to report signs of methotrexate toxicity such as sore throat, mouth ulcers, unexplained bruising or bleeding. ## Research Evidence Research on this interaction has shown mixed results: - A systematic review in the Cochrane Database suggested the two medications may be safe together, though the studies were of low to moderate quality. - A study of 15 patients with rheumatoid arthritis found that concomitant naproxen did not significantly alter the disposition of low-dose methotrexate in patients with normal renal function. ## Signs of Toxicity Patients taking this combination should be aware of potential signs of methotrexate toxicity, including: - Nausea and vomiting - Fever - Malaise - Diarrhea - Fatigue - Dizziness Healthcare providers may adjust the methotrexate dose for patients with reduced renal function to minimize the risk of toxicity. In conclusion, while there is a potential for interaction between methotrexate and naproxen, this combination is still commonly used in clinical practice with appropriate monitoring and precautions, particularly for patients with rheumatoid arthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Methotrexate + Naproxen.